[Skip to content]

tab rollover pre-load tab rollover pre-load tab rollover pre-load tab rollover pre-load tab rollover pre-load tab rollover pre-load
Wednesday 27 October 2021
Salford GP Header Montage
Latest News:
RSS icon
Medicine, tablets, pills


This is an electronic version of our Formulary written in conjunction with the Medicine Management Committee and the Pharmacy department.   The purpose of the Formulary is:

  • To promote safe, rational and cost effective prescribing within the Trust.
  • To help select the most appropriate drug amongst the many available.


This formulary is intended to act as a rapid reference source.  It is intended for the guidance of medical practitioners, nurses and other healthcare workers.


For local GPs and Non-medical prescribers working in the community there is the Greater Manchester Joint Formulary produced by the Greater Manchester Medicines Management Group (GMMMG).  The formulary ensures that patients receive seamless care across the primary-secondary care interface and reduces the need for switching programmes. All medicines recommended for use in the NHS in a NICE Technology Assessment (TA) are approved for use in Greater Manchester, the GMMMG site provides a list of medicines with a positive recommendation from  NICE and provides links to these TAs in the GMMMG formulary.  In the SRFT formulary below all the drugs with a positive NICE TA that are applicable to SRFT are included in the formulary.


How to use

All medicines are listed alphabetically using the generic name where possible.  Some brand names are used.


  1. Type the drug name in the 'Keywords' box

  2. Click on the 'Search' button

  3. Within the results, click on the 'generic name' of the medicine you are looking for.

  4. Click on the 'Link' - this will take you to further information that talks about that medicine. 



Drug NameBNF CategoryComment / Usage RestrictionsDetails
Otocomb Otic OintmentNo BNF entryUnlicensed in UK, Licensed in AustraliaFor use by ENT only for severe otitis externa as an alternative to Tri-adcortyl ointment, which was discontinued. Approved July 2012  
OxandroloneSee online BNFC1 inhibitor deficiency, prophylactic medication to reduce frequency of swelling attacks in patients intolerant to Danazol (NHSE guidance).Approved Sept 2017 as per proposed indication for initiation by Immunology Consultants only.   
Oxazepam4.1.2 AnxiolyticsRefer to Mental Illness Unit 
Oxybuprocaine 0.4% minims11.7 Local anaesthetics  
Oxybutynin7.4.2 Drugs for urinary frequency, enuresis and incontinenceApproved for adults and paediatrics  
Oxycodone Cd4.7.2 Opioid analgesics  
Oxytocin7.1.1 Prostaglandins and oxytocicsObs & gynae only 
Oxytocin With Ergometrine7.1.1 Prostaglandins and oxytocicsObs & gynae only 


All material in this section is aimed at health professionals, but is information currently held within the public domain.   Members of the public seeking advice on medicine-related matters are encouraged to speak with their GP, pharmacist or nurse, or contact NHS Direct on 0845 46 47.